Clinical utility of cell-free DNA for the detection of ALK fusions and genomic mechanisms of ALK inhibitor resistance in non-small cell lung cancer.
about
Clinical utility of cell-free DNA for the detection of ALK fusions and genomic mechanisms of ALK inhibitor resistance in non-small cell lung cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Clinical utility of cell-free ...... in non-small cell lung cancer.
@en
Clinical utility of cell-free ...... in non-small cell lung cancer.
@nl
type
label
Clinical utility of cell-free ...... in non-small cell lung cancer.
@en
Clinical utility of cell-free ...... in non-small cell lung cancer.
@nl
prefLabel
Clinical utility of cell-free ...... in non-small cell lung cancer.
@en
Clinical utility of cell-free ...... in non-small cell lung cancer.
@nl
P2093
P2860
P50
P1476
Clinical utility of cell-free ...... in non-small cell lung cancer.
@en
P2093
Alice T Shaw
Ben M Chue
Benjamin Levy
Caroline E McCoach
Christine E Lee
Collin M Blakely
Dara L Aisner
Joseph Diaz
Robert C Doebele
P2860
P304
P356
10.1158/1078-0432.CCR-17-2588
P407
P577
2018-03-29T00:00:00Z